The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker such as metoprolol or carvedilol or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes obesity or an obesity associated disorder.